New research published in Nature confirms that the antidepressant effects of psilocybin occur independently of the receptor that triggers hallucinations. By targeting specific brain pathways, scientists have successfully separated the therapeutic benefits from the "trip," opening doors to accessible new treatments.
(c) Marco Allegretti
(c) Marco Allegretti

La psilocibina trata la depresión sin causar alucinaciones

MEDICAL XPRESS

Nuevas investigaciones en Nature confirman que los efectos antidepresivos de la psilocibina ocurren independientemente del receptor que causa alucinaciones. Al dirigirse a vías cerebrales específicas, los científicos han logrado separar el beneficio terapéutico del «viaje», permitiendo tratamientos más accesibles.

Read Full Story

Entradas relacionadas

Los Más Leídos

In recent years, the amount of drug deaths among people in their 20s has begun to decrease, based on data collected by the CDC. While the exact reason for the drop is unclear, theories include access to resources, less deadly drugs and loss of other young people.
Vacuna contra fentanilo inicia su primer ensayo humano para frenar sobredosis
In Senegal’s Kedougou region, local communities are choosing wildlife conservation over hazardous gold mining. By becoming eco-guides, former miners protect endangered western chimpanzees while earning a stable income. This shift preserves vital habitats and ensures a safer, sustainable future for both people and nature.
Chimpancés de Senegal: del trabajo en las minas al turismo natural
A mosque in Bradford, England, is leading a health revolution by hosting dedicated pilates sessions for men to improve their physical and mental wellbeing. These popular classes offer a welcoming space for all ages to build strength and lasting bonds, showing how community hubs can foster vitality and unity.
Hombres de Bradford encuentran salud y amistad con pilates
Researchers at the University of Cologne have discovered a powerful antibody — 04_A06 — that neutralizes around 98.5 % of over 300 tested HIV strains. In lab experiments the antibody reduced viral load to undetectable levels — a major step toward broad-spectrum therapies for prevention and treatment worldwide.
Gran avance contra el VIH: anticuerpo neutraliza casi todas las variantes